Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Veto of Prescription Drug…
Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB)…
Learn more
BIO Statement on Resignation of FDA Commissioner…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…
Learn more
BIO Launches “The Fight of Our Lives,” a National…
WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of ​​The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
Convention Programming to Feature “One Health” Concept
May 11, 2017
Bio-based Technologies Address Human, Animal, Plant and Environmental Health Washington, D.C. (May 11, 2017) – At its heart, the concept of One Health is rooted in the notion that the health of humans, animals, and the environment are all…
Ann Romney to Deliver Keynote at 2017 BIO International Convention
May 10, 2017
Former First Lady of Massachusetts and New York Times best-selling author will speak about the power of resilience in overcoming obstacles, advocating for families and spearheading brain health research
BIO Congratulates Dr. Scott Gottlieb on Confirmation as FDA Commissioner
May 9, 2017
Washington, DC (May 9, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the confirmation of Dr. Scott Gottlieb as Commissioner of the Food and Drug Administration (FDA):
BIO Thanks Sen. Wyden for Clean Fuel Production Tax Credit Proposal
May 4, 2017
BIO today thanked Sen. Ron Wyden (D-OR) and 21 Senate co-sponsors for proposing a technology neutral tax credit for domestic production of clean transportation fuel. Sen. Wyden’s Clean Energy for America Act proposes a set of long-term energy tax…
BIO Applauds Bipartisan Introduction of the PARTNER Act
May 4, 2017
Washington, DC (May 4, 2017) – Today, the Biotechnology Innovation Organization (BIO) thanks Reps. Pat Meehan (R-PA), Richard Neal (D-MA), Mike Kelly (R-PA), Ron Kind (D-WI), and John Larson (D-CT) for introducing the Partnerships to Advance…
BIO Partners with NIH and NSF for Fourth “Innovation Zone” Exhibit
May 4, 2017
SBIR-funded companies will showcase biotechnology breakthroughs at BIO 2017 International Convention 
Report Shows GM Crops Favored by World’s Farmers
May 4, 2017
Global Adoption of Biotech Crops Reaches New Peak of 457 Million AcresWashington, D.C. (May 4, 2017) – Millions of farmers around the world continue to choose genetically modified (GM) crop varieties because of their environmental and socio-economic…
BIO Statement on Blue Cross Blue Shield Prescription Drug Spending Report
May 3, 2017
Washington, DC (May 3, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding today’s prescription drug spending report from Blue Cross Blue Shield: “Today’s report from…
BIO World Congress Announces New Education Track and Plenary Session on Food Ingredients and Personal Care
May 2, 2017
The 2017 BIO World Congress on Industrial Biotechnology education program features seven diverse education tracks with speakers from around the world over three days of the conference.
BIO Statement on Release of USTR’s 2017 “Special 301 Report”
May 1, 2017
USTR’s 2017 report addresses many of the key IP-related challenges that BIO members face globally.